Literature DB >> 25070495

The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature.

Linda Ryen1, Mikael Svensson1,2.   

Abstract

There has been a rapid increase in the use of cost-effectiveness analysis, with quality adjusted life years (QALYs) as an outcome measure, in evaluating both medical technologies and public health interventions. Alongside, there is a growing literature on the monetary value of a QALY based on estimates of the willingness to pay (WTP). This paper conducts a review of the literature on the WTP for a QALY. In total, 24 studies containing 383 unique estimates of the WTP for a QALY are identified. Trimmed mean and median estimates amount to 74,159 and 24,226 Euros (2010 price level), respectively. In regression analyses, the results indicate that the WTP for a QALY is significantly higher if the QALY gain comes from life extension rather than quality of life improvements. The results also show that the WTP for a QALY is dependent on the size of the QALY gain valued.
Copyright © 2014 John Wiley & Sons, Ltd. Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  QALY; literature review; willingness to pay

Year:  2014        PMID: 25070495     DOI: 10.1002/hec.3085

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  54 in total

1.  Quality-adjusted cost of care: a meaningful way to measure growth in innovation cost versus the value of health gains.

Authors:  Darius Lakdawalla; Jason Shafrin; Claudio Lucarelli; Sean Nicholson; Zeba M Khan; Tomas J Philipson
Journal:  Health Aff (Millwood)       Date:  2015-04       Impact factor: 6.301

2.  Value of a QALY and VSI estimated with the chained approach.

Authors:  S Olofsson; U-G Gerdtham; L Hultkrantz; U Persson
Journal:  Eur J Health Econ       Date:  2019-06-06

3.  Measuring the end-of-life premium in cancer using individual ex ante willingness to pay.

Authors:  S Olofsson; U-G Gerdtham; L Hultkrantz; U Persson
Journal:  Eur J Health Econ       Date:  2017-08-12

4.  When is it too expensive? Cost-effectiveness thresholds and health care decision-making.

Authors:  Werner Brouwer; Pieter van Baal; Job van Exel; Matthijs Versteegh
Journal:  Eur J Health Econ       Date:  2019-03

5.  Cost Effectiveness of Nutrition Policies on Processed Meat: Implications for Cancer Burden in the U.S.

Authors:  David D Kim; Parke E Wilde; Dominique S Michaud; Junxiu Liu; Lauren Lizewski; Jennifer Onopa; Dariush Mozaffarian; Fang Fang Zhang; John B Wong
Journal:  Am J Prev Med       Date:  2019-09-26       Impact factor: 5.043

6.  Evaluating the Cost-Effectiveness of an Early Detection of Parkinson's Disease through Innovative Technology.

Authors:  David A Munoz; Mehmet Serdar Kilinc; Harriet B Nembhard; Conrad Tucker; Xuemei Huang
Journal:  Eng Econ       Date:  2017-03-22       Impact factor: 0.861

7.  How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13.

Authors:  Stephen Martin; James Lomas; Karl Claxton; Francesco Longo
Journal:  Appl Health Econ Health Policy       Date:  2021-07-21       Impact factor: 2.561

8.  The societal monetary value of a QALY associated with EQ-5D-3L health gains.

Authors:  Laura Vallejo-Torres; Borja García-Lorenzo; Oliver Rivero-Arias; José Luis Pinto-Prades
Journal:  Eur J Health Econ       Date:  2019-11-28

9.  Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment.

Authors:  David D Kim; Gregory F Guzauskas; Caroline S Bennette; Anirban Basu; David L Veenstra; Scott D Ramsey; Josh J Carlson
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

10.  Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration.

Authors:  E Losina; G Michl; J E Collins; D J Hunter; J M Jordan; E Yelin; A D Paltiel; J N Katz
Journal:  Osteoarthritis Cartilage       Date:  2015-12-31       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.